1 / 31

Bipolar Disorder

Bipolar Disorder. Use of therapeutic drugs in the treatment of mental health. What is Bipolar Disorder?. Also known as Manic-Depression Typifies mood swings from high and irritable (mania) to utter hopelessness outside of everyday blues (depressive). 2 million Americans suffer from it

della
Download Presentation

Bipolar Disorder

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Bipolar Disorder Use of therapeutic drugs in the treatment of mental health.

  2. What is Bipolar Disorder? • Also known as Manic-Depression • Typifies mood swings from high and irritable (mania) to utter hopelessness outside of everyday blues (depressive). • 2 million Americans suffer from it • Runs in families and seen to be inherited. • Usually begins in early adulthood and remains possibly through entire life span.(American Journal of Psychiatry & www. nimh.com)

  3. MORE INFO…. • Uncommon under age of 12 but, careful diagnosis must be made due to similarity with ADD/ADHD. • People who suffer have serious behavioral problems with consequences. (Spending Sprees, Instant Gratification, etc.) • Effects Relationships with loved ones. (www.APA.com, Psychiatry, www.nimh.com, & Journal of the American Academy of Child & Adolescent Psychiatry)

  4. Mood Swings (Mania) • Restlessness, racing thoughts, and rapid talking. • Excessive high thoughts • Irritability • Decreased need for sleep • Lack of Good Judgement • Increased Sexual Drive • Aggressiveness (American Psychiatric Association: DSM-IV, 1994)

  5. Mood Swings…Depression • Sad, anxious or empty mood • Feeling of Hopelessness • Loss of interest in activities • Constant Fatigue • Lack of Concentration • Loss of appetite and change of weight • Contemplation of death or suicide (DSM-IV)

  6. Causes of Bipolar Disorder • Genetic Factors (X-Linked) • Biological Factors • Norepinephrine and Serotonin Levels (American Journal of Psychiatry & Psychiatry, 1990)

  7. Treatment • Therapeutic Drugs • ECT (Electroconvulsive Therapy) • Counseling/Psychotherapy

  8. Therapeutic Drugs • Lithium • Valproate • Carbamazepines • Neuroleptics • Benzodiazapines • Anti-depressants

  9. History of Lithium • Used in 1920’S as a sedative-hypnotic compound and anticonvulsant drug • 1940’s saw it as a salt substitute for those with heart disease • First recorded to have antimanic effects in 1949 by J. Cade’s Guinea Pig Test • Widespread use since 1960’s (A Primer of Drug Action. Julien, 1997)

  10. Use of Lithium • Most effective in Bipolar Disorder episodes and prevention (National Mental Health Association)

  11. Response to Medication

  12. Use of Lithium • Most effective in Bipolar Disorder episodes and prevention • Decreases Mood Instability Between Episodes in mania and depression • Patients have difficulty complying with Lithium-leads to reoccurrence • Lithium=Li+ (Julien, 1997 & AJOP)

  13. Pharmacokinetics • Available in Tablets or Capsules as the carbonate salt • Found in syrups as the citrate form • Peak blood levels range from (1-2 hrs. NIOMH; 3 hrs. Julien) • Crosses the blood brain barrier slowly and incompletely (Julien)

  14. Pharmacokenetics cont... • Lithium is excreted by the kidneys in two phases (Julien), vs. • Lithium is excreted entirely in one phase (NIOMH) • Phase 1 (half life)- (14 to 30 hours NIOMH & 18 to 24 hours Julien) • Phase 2-next two weeks (Julien)

  15. More Pharmacokinetics…. • Most closely monitor therapeutic dose with blood levels • Lithium has very narrow therapeutic window (toxicity and side effects) • At controlled episodes blood levels between 0.5 and 0.9 is recommended as a “target level” (Julien & American Journal of Psychiatry )

  16. Silverstone and Romans, 1996 • “ A level much below this is likely to be associated with a greater likelihood of relapse, while a higher one is frequently accompanied by more adverse effects, leading to an increased risk of noncompliance.”

  17. Pharmacodynamics • Lithium may increase presynaptic reuptake of norepinephrine and serotonin • May decrease the release of both norepinephrine • May interfere with the movements of intracellular calcium ions • Lithium interfere with second-messenger in the post-synaptic neuron

  18. Side Effects of Lithium • Weight Gain • Cognitive Problems • Tremor • Sedation or Lethargy • Impaired Coordination • Gastrointestinal distress • Hair Loss • Benign Leukocytes • Acne (DSM-V)

  19. Considerations • Checking medical background • Non-compliance • Psychological Support, Family Therapy, and other treatments (NIOMH, American Journal of Psychology & Julien)

  20. Valproate • Studied alone and in conjunction with other mood stabilizers • In manic patients improvement seen in 3 days • Also an antiepileptic drug • May lower white blood cell count of those who struggle with alcoholism and bipolar disorder (APA & American Journal of Psychiatry)

  21. Pharmacokinetics • Available in capsules and syrups • Rapidly absorbed after ingestion • Peak serum concentration is reached after 2 hours • Half-life ranges from 6-16 hours • Relationship with mood stabilizing is not fully defined • Valproate is metabolized by the liver and contain much protein (AJOP)

  22. Side Effects • Gastrointestinal Problems (upset stomach) • Sedation • Lethargy • Hand Tremor • Loss of Hair • Metabolic changes in the liver • May be risk to fetus during pregnancy (1-2% suffer adverse affects) (Julien & Canadian Family Physician)

  23. Implementing Treatment • A general medical history SHOULD be taken with a focus on hepatic, hematological, and bleeding abnormalities • Continual blood tests should be given to check liver functions throughout patients usage. (At least every 6 months) • Normal Dosage: 750 mg in 2 doses (American Psychological Association)

  24. Other Uses of Valproate • Antiepileptic • Personality Disorders • Behavioral Dyscontrol (agitation, aggression, temper outbursts) • Migraine (APA, AJOP & www.athealth.com)

  25. Carbamazepine • Studied alone and in conjunction with other mood stabilizers • Lithium more effective; Neuroleptics same (APA) Just as effective as lithium (Julien) • Those who fail to respond usually do not have the correct dosage (Julien)

  26. Pharmacokinetics • Available in a wide variety of forms: solutions, suspensions, syrups, and newly developed chewable and slow release formulations • Elimination half-life ranges from 18-55 hours • With maintenance treatment carbamazepine induces its own half-life and may decrease to 5-26 hours (APA)

  27. Side effects of carbamazepine • Gastrointestinal upset • Sedation • Visual Disturbances • Dizziness • Overdoses may be fatal (Julien)

  28. Neuroleptics • Lithium is better for long-term treatment, neuroleptics are best for quick action • Typically seen in psychotic patients • Used prior to mood stabilizers and sometimes in conjuction • Drug: Clozapine & Risperdone (American Journal of Psychiatry)

  29. Benzodiazapines • Benzodiazapines-used in conjunction with neuroleptics • Not as effective as antidepressants • Risk: further depression • Benefit: Sleep for the insomniac (APA)

  30. Antidepressants • Mainly used in conjunction with Lithium • Should have lowest dose for the shortest amount of time • Risk: May lead to further depressive states and ruin response to mood stabilizer

  31. Recent trends • Self-medicating herbal products (St. John’s Wort) • Herbal Products are dangerous when used and not effective then additional drugs used • Most effective when used in conjunction with psychotherapy (AJOP)

More Related